One study published in the British Journal of Dermatology in 2015 assessed the effectiveness of minoxidil as a treatment for ...

Over the past 15 years, Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products. CRISPR Therapeutics won its first regulatory ...

Many people experience an itchy scalp at some point. It’s usually not a sign of a serious medical condition and can, in most cases, be successfully treated with home remedies, over-the-counter ...

Google Cloud’s latest enhancements to Vertex AI and the Gemini model family offer businesses a comprehensive solution for building, deploying, and managing AI applications with unprecedented ...

Zimislecel (VX-880) pivotal trial on track to complete enrollment and dosing in H1 2025; Vertex expects to submit marketing applications to global regulators in 2026 - Vertex has completed ...

This treatment is packed with hydrating, anti-inflammatory ceramides to prevent moisture loss and strengthen the skin barrier on the scalp — plus, it contains Olaplex’s proprietary bond ...

Vertex Pharmaceuticals (VRTX) announced several updates on the company’s type 1 diabetes portfolio. Vertex has completed enrollment and dosing in Parts A and B of the Phase 1/2 VX-264 study and ...

Intuitive Surgical is targeting a huge opportunity for its robotic surgical systems. Vertex Pharmaceuticals should have a smashing commercial success story with its new non-opioid pain drug.

Leading industry experts join the Vertex Chief Strategy Office to shape product innovation and strengthen global compliance strategies for customers KING OF PRUSSIA, Pa., April 10, 2025 (GLOBE ...